English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
UK survival ranks among the worst in the world for deadliest cancers
UK survival ranks among the worst in the world for deadliest cancers
High-dose radiotherapy with chemotherapy effective in treating people with non-small cell lung cancer
High-dose radiotherapy with chemotherapy effective in treating people with non-small cell lung cancer
European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line treatment of patients with EGFR-mutated NSCLC
European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line...
Inhalable sensors could enable early lung cancer detection
Inhalable sensors could enable early lung cancer detection
Protein structures signal fresh targets for anticancer drugs
Protein structures signal fresh targets for anticancer drugs
Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening
Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening
A type of allergy medicine might help treat lung cancer, research suggests
A type of allergy medicine might help treat lung cancer, research suggests
AI identifies non-smokers at high risk for lung cancer
AI identifies non-smokers at high risk for lung cancer
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests
FDA approves repotrectinib for ROS1-positive non-small cell lung cance
FDA approves repotrectinib for ROS1-positive non-small cell lung cance
<1...2223242526...262>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top